The cost‐effectiveness of platelet additive solution to prevent allergic transfusion reactions
- 30 January 2013
- journal article
- blood componants
- Published by Wiley in Transfusion
- Vol. 53 (11), 2609-2618
- https://doi.org/10.1111/trf.12095
Abstract
Background Allergic transfusion reactions (ATRs) are among the most common complications of transfusion. Storage in platelet additive solution (PAS) has been shown to reduce ATRs from apheresis platelets (APs). This study evaluated the cost‐effectiveness of using PAS storage as an alternative method to reduce ATRs. Study Design and Methods A Markov‐based decision tree was constructed to compare ATR rates and associated costs expected from current practice and from alternative strategies of using APs stored in PAS. The potential use of pretransfusion medication was also incorporated. Using a hospital perspective and including direct medical expenses only (US$2012), Monte Carlo microsimulations were run to evaluate outcomes under a base‐case analysis. One‐way and probabilistic sensitivity analyses were used to assess outcome uncertainty. Results Under base‐case variables, using APs stored in PAS for all patients as an initial transfusion protocol is expected to avert ATRs and associated costs, compared to current practice. Using PAS for all patients along with pretransfusion medication would be cost‐saving only when the additional cost of PAS is below $9.14. If PAS storage could eliminate pretransfusion medication use, it is expected to result in cost savings when the additional unit cost of PAS is under $11.90. At a PAS cost of $15, averting one ATR would cost $701.95. Using PAS storage only in response to recurring mild ATRs is associated with cost savings under all costs of PAS evaluated. Conclusions Using PAS storage for all AP transfusions to prevent ATRs may be financially and clinically beneficial, compared to current practice.This publication has 24 references indexed in Scilit:
- Using lean techniques to define the platelet (PLT) transfusion process and cost‐effectiveness to evaluate PLT dose transfusion strategiesTransfusion, 2012
- The impact of apheresis platelet manipulation on corrected count incrementTransfusion, 2012
- Current status of additive solutions for plateletsJournal of Clinical Apheresis, 2012
- Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United StatesJournal of Allergy and Clinical Immunology, 2011
- Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributesTransfusion, 2011
- Additive solutions for platelets: is it time for North America to go with the flow?Transfusion, 2009
- Pathogen inactivation: making decisions about new technologiesTransfusion, 2007
- An Introduction to Markov Modelling for Economic EvaluationPharmacoEconomics, 1998
- Markov Models in Medical Decision MakingMedical Decision Making, 1993
- Reduction of the volume of stored platelet concentrates for use in neonatal patientsTransfusion, 1984